Patents Assigned to Hb Therapeutics Inc.
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20240287098
    Abstract: The present invention relates to the field of anti-cancer compounds. More particularly, the invention relates to a family of benzothiazolyl urea or thiorurea compound useful as such agents. The present invention also relates to methods for treating cancers using these compounds.
    Type: Application
    Filed: June 30, 2023
    Publication date: August 29, 2024
    Applicant: Hb Therapeutics Inc.
    Inventors: Anita Bellail, Chunhai Hao, Ho Yin Lo
  • Compositions and methods for treating cancer
    Patent number: 11731985
    Abstract: The present invention relates to the field of anti-cancer compounds. More particularly, the invention relates to a family of benzothiazolyl urea or thiorurea compound useful as such agents. The present invention also relates to methods for treating cancers using these compounds.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: August 22, 2023
    Assignee: Hb Therapeutics Inc.
    Inventors: Anita Bellail, Chunhai Hao, Ho Yin Lo
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20210115064
    Abstract: The present invention relates to the field of anti-cancer compounds. More particularly, the invention relates to a family of benzothiazolyi urea or thiorurea compound useful as such agents. The present invention also relates to methods for treating cancers using these compounds.
    Type: Application
    Filed: May 8, 2019
    Publication date: April 22, 2021
    Applicant: Hb Therapeutics Inc.
    Inventors: Anita Bellail, Chunhai Hao, Ho Yin Lo